"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)
Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream. In data presente.....»»
Sibley’s proton therapy center is open. Here’s a look inside.
Sibley Memorial Hospital has started treating patients with proton therapy, making it the second D.C. hospital to offer the cancer treatment. The hospital, owned by Johns Hopkins Medicine, opened its new 80,000-square-foot proton beam therapy center,.....»»
Stanford, UCSF double down on East Bay cancer care
Smaller facilities can be closer to patients and cut down on travel for treatment......»»
AstraZeneca Makes Great Prostate Cancer Treatment Showing, Targeting Specific Molecular Biomarker Patients
AstraZeneca Makes Great Prostate Cancer Treatment Showing, Targeting Specific Molecular Biomarker Patients.....»»
Eli Lilly Throws Hat In The Ring For Lung Cancer Space, Takes Targeted Treatment Approach
Eli Lilly Throws Hat In The Ring For Lung Cancer Space, Takes Targeted Treatment Approach.....»»
Surprising Reaction to Lung Cancer Study Results
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer......»»
Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful
Novartis has nabbed the U.S. Food and Drug Administration's breakthrough therapy designation for its experimental medicine capmatinib as it joins Pfizer in the race to treat a tough-to-treat mutated lung cancer type......»»
What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high......»»
AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study
AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»
Upgrade: 5 foods to start eating now if you want to live a longer life
What we eat and drink can impact our likelihood of dying from cancer and heart disease.....»»
AstraZeneca"s Imfinzi Gains Orphan Drug Status for SCLC
The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the mo.....»»
AstraZeneca"s durvalumab granted orphan designation as lung cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx
Puma Biotech (PBYI) files an sNDA for the nod of Nerlynx in combination with Xeloda to treat patients with HER2-positive metastatic breast cancer, having failed two or m.....»»
Merck Throws Its Hat Into The Ring With Keytruda For Treating Subset Of Lung Cancer Patients
Merck Throws Its Hat Into The Ring With Keytruda For Treating Subset Of Lung Cancer Patients.....»»
Roswell Park partners with biotech firm to develop immunotherapy treatment
Roswell Park Comprehensive Cancer Center is partnering with a San Diego firm to develop a new way to see and treat cancer tumors. Researchers are working with OncoSec Medical Inc. (NASDAQ: ONCS) to develop a system to for using intravital microsco.....»»
Pfizer expands in cancer treatment with $10.6 billion deal for array
Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patients......»»
Iovance and Amgen Are Making Cancer History
Advances by the two companies offer hope for patients and may attract more investment in unique approaches to difficult forms of the disease......»»
Amgen"s early-stage study of cancer treatment had "adverse events" in nearly half of its patients
Amgen Inc. said Wednesday data from phase 1 studies of an investigational bispecific T cell engager (BiTE) molecules, updated with investigational AMG 420 results for the treatment .....»»
Meet One of ASCO’s First Losers
Turning Point Therapeutics shares dipped on Friday after the firm posted interim data for its midstage study in ROS1-positive non-small cell lung cancer patients......»»
Houston nonprofit opens new facility dedicated to cancer patients
A little longer than a year after breaking ground, the Halo House Foundation on May 15 hosted a grand opening of its new facility dedicated to out-of-town blood cancer patients. The new 42,520-square-foot building at 2940 Corder St. has 33 apartmen.....»»
Novartis gets FDA nod for advanced breast-cancer treatment
Novartis AG said late Friday the U.S. Food and Drug Administration has approved one of its treatments for a type of advanced breast cancer afflicting patients carrying a gene.....»»